NOTCH4 and neoplasm: Our results show that targeting Notch4 specifically alters perfusion and vessel area, contributing to improved tumor control in single or combination therapy; thus, these novel Notch4-blocking antibodies represent a powerful new tool for altering the tumor vasculature.